Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 03 03 2020
revised: 24 04 2020
accepted: 29 04 2020
pubmed: 17 6 2020
medline: 25 6 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

To address the faecal carriage prevalence of antibiotic-multiresistant bacteria and associated risk factors in a public long-term care facility (LTCF). A prospective study in a single government-funded LTCF of 300 residents in Ciudad Real, Spain. Residents' clinical and demographic data were collected, as well as recent antibiotic consumption in the institution. Each participant contributed a rectal swab, which was plated on selective and differential-selective media. Colonies were identified by MALDI-TOF and ESBL production was confirmed by the double-disc synergy method, with characterization of the molecular mechanism by PCR. Isolates were typed by PFGE and submitted for ST131 screening by PCR. Faecal carriage of ESBL-producing Enterobacterales was detected in 58 (31%) of 187 participants and previous infection by MDR bacteria was identified as a risk factor. The genes characterized were: blaCTX-M-15 (40.6%); blaCTX-M-14 (28.8%); blaCTX-M-27 (13.5%); and blaCTX-M-24 (10.1%). Some 56.4% of the isolates were grouped into the E. coli ST131 clone; 70.9% of these corresponded to the O25b serotype, 51.6% of them to Clade C1 (H30) and 12.9% to Clade C2 (H30Rx). Clade C1 isolates were mostly C1-M27, whereas the C2 sublineage was mainly related to the production of CTX-M-15. ST131-CTX-M-24 isolates (n = 6) corresponded to Clade A with serotype O16. A high prevalence of ESBL-producing Enterobacterales faecal carriage has been detected in a single LTCF, highlighting the emergence of ST131 Clade A-M24 and Clade C1-M27 lineages.

Identifiants

pubmed: 32542354
pii: 5857665
doi: 10.1093/jac/dkaa219
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2480-2484

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Cristina Colmenarejo (C)

Department of Microbiology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.

Marta Hernández-García (M)

Department of Microbiology, Hospital Universitario Ramón y Cajal and Ramón y Cajal Health Investigation Institute (IRYCIS), Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI-RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.

José Ramón Muñoz-Rodríguez (JR)

Translational Research Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.

Natalia Huertas (N)

Department of Microbiology, Hospital Universitario Ramón y Cajal and Ramón y Cajal Health Investigation Institute (IRYCIS), Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI-RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.

Francisco Javier Navarro (FJ)

Long-term care facility Gregorio Marañon, Ciudad Real, Spain.

Ana Belén Mateo (AB)

Long-term care facility Gregorio Marañon, Ciudad Real, Spain.

Eva María Pellejero (EM)

Long-term care facility Gregorio Marañon, Ciudad Real, Spain.

Soledad Illescas (S)

Department of Microbiology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
Department of Microbiology, Faculty of Medicine, University Castilla-La Mancha, Ciudad Real, Spain.

María Dolors Vidal (MD)

Department of Microbiology, Faculty of Medicine, University Castilla-La Mancha, Ciudad Real, Spain.
Grupo Emas, Centro Regional de Investigaciones Biomédicas (CRIB), Albacete, Spain.

Rosa Del Campo (R)

Department of Microbiology, Hospital Universitario Ramón y Cajal and Ramón y Cajal Health Investigation Institute (IRYCIS), Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI-RD12/0015), Instituto de Salud Carlos III, Madrid, Spain.
University Alfonso X El Sabio, Villanueva de la Cañada, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH